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ABSTRACT
Background The Alzheimer’s Society wished to
raise awareness that people with memory problems
may beneﬁt from early assessment and diagnosis, so
that appropriatemeasures could be put in place and
management improved.
Objective To use routinely collected data to deter-
mine whether a leaﬂet campaign to raise awareness
of memory problems would result in increased
presentation of people with memory problems to
their GPs.
Method A locality was identiﬁed which met the
criteria for locating the pilot intervention. A neigh-
bouring locality was identiﬁed which used the same
secondary care service and could serve as a com-
parator. Anonymised routinely collected computer
data were gathered before and after the interven-
tion.
Results The intervention locality had a much
greater proportion of elderly patients and a higher
proportion had memory problems recorded at
baseline (OR 1.67; 95% CI 1.47–1.91; P<0.001).
In both localities just under 40% of people with
memory problems had blood tests. Approximately
80% would be referred to secondary care, and this
was more likely for those in the intervention group
(OR 1.29; 95% CI 0.99–1.93; P=0.044).
However, the use of antidepressants was greater
in the control locality; 34% vs 9% (OR 0.19; 95%CI
0.13–0.27; P<0.001).
Whilst the absolute number of people prescribed
cholinesterase inhibitors was greater and increased
more in the intervention practices, the proportion
of people with memory problems prescribed was
not signiﬁcantly greater (OR 1.21; 95% CI 0.77 –
1.89; P=0.38). The increased prescribing in the
intervention practices was due to people restarting
therapy. From a lower baseline there was a greater
increase in the control locality for all variables for
which we had a before and after measure.
Conclusions During a leaﬂet campaign the record-
ing andmanagement ofmemory problems increased.
However, there was greater improvement in the
control locality. This study demonstrates the im-
portance of including a control group and the
strengths of routine primary care data.
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Introduction
Patients with memory problems may beneﬁt from
assessment and treatment. Assessment may identify
problems which can be rectiﬁed. These include physical
health problems, which are easily detected by simple
blood tests, or depression. Diagnosis of dementia is a
specialist task best done by experienced clinicians with
access to appropriate sophisticated investigations, which
usually requires referral to a memory assessment ser-
vice.1Much can be achieved through teamworkwhich
includes primary care.2–5 In the UK the use of drug
treatment for dementia has been an area of contro-
versy since the National Institute for Health and
Clinical Excellence (NICE) rejected the proposal that
antidementia drugs should be more widely used.6–8
However, even if the place of some therapeutic agents
remains undecided,9 if diagnosis is delayed people
with memory problems and their carers may remain
unsupported for much longer than necessary.10 It is
consequently generally recognised that early diagnosis
may beneﬁt treatment and management strategies in
dementia.11,12
The Alzheimer’s Society wanted to assess the eﬀect
of a leaﬂet campaign, which they subsequently launched
nationally,13 to encourage people with memory prob-
lems to attend their GP. They planned to pilot this
campaign in an area where the society was active and
could oﬀer additional support should additional people
and their carers be identiﬁed as a result of this pro-
gramme. Further criteria were that the area should
have an above average population of over 55-year-olds
and an activememory clinic. The campaignwas run by
the local branch of the Society and focused on distrib-
uting leaﬂets to public buildings such as libraries,
pharmacies and general practice and dental surgeries,
as well as through branch activities, community centres
and on request. There was also a direct mailing to
general practitioners (GPs) to tell them about the
campaign. The evaluation of the campaignwas carried
out from a number of perspectives: response rate to
the Society by phone and post; referral to their branches;
and by monitoring the impact on GP services. A copy
of the leaﬂet is shown in Figure 1.
In the UK, primary care is highly computerised and
aggregated routine data used to monitor achievement
of quality targets are in the public domain. Computers
are used at the point of care with data entry largely
completed by clinicians.14 A national system of regis-
tration allows patients to register with a single prac-
tice: electronic prescribing, electronic communication
of pathology results and the introduction of pay for
performance (P4P), based on data collected for usual
clinical care, have all led to an improvement in data
quality.15,16
Figure 1 Alzheimer’s Society leaﬂet: Worried about your memory?
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This report describes the use of routine data to
measure the impact of this leaﬂet campaign on local
GP services.
Method
We carried out a literature review to identify evidence
for early presentation of patients with memory prob-
lems to general practice and the impact of leaﬂet cam-
paigns on quality improvement. We searched the
principal bibliographic databases Medline and Embase.
We examined the reference lists and ‘related articles’
from Medline searches.
We identiﬁed an intervention locality, which re-
ferred to the same specialist service as a neighbouring
control locality. The two localities shared local pre-
scribing policy and availability of secondary care
services.
We evaluated the intervention using routinely col-
lected GP computer data. We opted to use areas of the
record which we expected to be reliably recorded:14,17,18
1 The recording of diagnosis or problem title of any
type ofmemory problem or dementia.We grouped
together the people with coding ranging from
recording of forgetfulness through to formal diag-
nosis of dementia.
2 The recording of the investigations for treatable
causes of memory problems. GPs commonly carry
out a ‘dementia screen’ to identify treatable causes
or comorbidities in people withmemory problems.
Electronic links from pathology labs to GP com-
puter systems facilitates their recording in the clin-
ical record. These investigations are recommended
as best practice.1 We decided to count people who
had had four or more recommended tests simul-
taneously as having had these investigations.
3 GPs may start people with memory problems on
antidepressants if they consider the condition likely
to be ‘pseudo-dementia’. We therefore decided to
look at new starters on antidepressants, and people
who had computer record entries suggesting that
they had been questioned using standardised exer-
cises (such as the Hospital Anxiety and Depression
Scale, the Beck Depression Inventory and the nine-
item Patient Health Questionnaire (PHQ-9) de-
pression rating scale) to assess whether they were
depressed.19
4 We expected to see people who present with mem-
ory problems being referred to secondary care. It is
national policy to refer people with impaired cog-
nitive function for assessment, ideally in a memory
clinic.1
5 Finally, we reported on the use of antidementia
drugs. The pros and cons of their use other than in
moderate or moderate to severe cases has been
reported in the introduction. We wanted to see if
the campaign was associated with any increased
prescribing.
We agreed within the research team (which included
representatives of the Alzheimer’s Society) a dataset
likely to identify the changes (Box 1). We looked at
rates of recording for the ten months before and after
the leaﬂet campaign of our target dataset.
We collected anonymised data from general prac-
tice computer systems using Morbidity Information
and Export Syntax (MIQUEST). MIQUEST is a De-
partment of Health sponsored application which allows
data extraction from the diﬀerent brands of GP com-
puter system.20
We aggregated the data and processed it using an
established methodology.21 This involved creating a
large, single data table, with controlledmetadata headers
for each columnof data and one line per patient.22 The
individualpatient’s identity ispseudonymised–replaced
by a unique numberwhich can only be decodedwithin
the originating practice. These data were transferred
into a statistical package for analysis (SPSS version 15).
We used descriptive statistics to describe these data
and odds ratios (OR) with 95% conﬁdence intervals
(95% CI) and the probability of this happening by
chance (P values) to compare control and inter-
vention practices.
We obtained consent fromamedical research ethics
committee to conduct this evaluation. Individual
practices that supplied data provided written consent.
Box 1 The dataset to evaluate the impact
of the memory problems leaﬂet
campaign
Demographic details Year of birth, gender, eth-
nicity
Problem titles Confused, forgetful, Alzheimer’s,
dementia, depression (as diagnosis or symptom),
stress, panic disorder, anxiety, change in person-
ality, senile/pre-senile organic psychosis, schizo-
phrenia, obsessive–compulsive, alcohol and drug
dependence, mental health ‘exception codes’
Investigations Rating scales for depression, blood
pressure, full blood count, renal function, liver
function, cholesterol and lipids, thyroid function
tests
Therapy Antidepressants, antipsychotics, anti-
mania, hypnotics and anxiolytics therapy
Referral Routine and emergency referral codes
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Results
The 14 intervention practices had a combined popu-
lation of 88 924. Their mean list size was 6352 and the
practice size ranged from 2837 to 11 717. The control
locality consisted of seven practices and had a smaller
population of 53 863. Themean list size of the controls
was 7695 and they ranged from 2708 to 11 912. The
proportion of those over 55 years old was above the
national average in the intervention practices, whereas
in the control locality the population over 65 years was
below the national average (see Figures 2 and 3).
Ethnicity recording was poor and so is not reported.
In the intervention practices it ranged from 0% to
2.7%; in the controls from 0% to 4.7%. Overall, only
0.7% of the intervention and 1.1% of the control
practices had records of ethnicity.
The recorded prevalence of memory problems
increased with age. Just under 1% of the population
(0.8%, n=1186) were recorded in GP information
systems as having memory problems. The proportion
rose to 2.5% of the population over 55 years old: 2.9%
of women and 2.1% of men. The intervention locality
had nearly the twice the prevalence of memory prob-
lems and dementia recorded at baseline (OR1.67; 95%
CI 1.47–1.91; P<0.001). The diﬀerence in recorded
prevalence between the intervention and control
practices was almost entirely accounted for by the
increased proportion of over 85-year-olds with mem-
ory problems in the intervention group (Table 1). The
proportion of people presenting with memory prob-
lems in all other age bands was similar in both groups
of practices, varying by less than 0.1%.
However, the rise in recording ofmemory problems
was faster in the control than in the intervention
practices. In the intervention locality there were 287
(0.32%) new ‘incident’ cases recorded in the before
period and 369 (0.42%) in the after period. The rate of
recording of cases rose by just under one-third (29%).
In the control locality there were 78 (0.15%) incident
cases before the intervention and 128 (0.24%) after, a
rise of just under two-thirds (64%).
Young people with memory problems were much
more likely to have had investigations for treatable
causes than people without memory problems in the
Figure 2 Age–sex pyramid comparing the intervention population with the English 2001 census population
Figure 3 Age–sex pyramid comparing the control practice population with the English 2001 census population
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same locality; with increasing age people withmemory
problems are no more likely to be investigated than
those without (Table 2). The rate of investigation of
patients with and without memory problems was
consistent between both localities. Overall, just under
40%of peoplewithmemory problems had blood tests;
there was no diﬀerence in this between the localities
(OR 0.95; 95% CI 0.72–1.25; P=0.71)
There was greater than threefold use of anti-
depressants in the control group (Table 3). In all age
groups the control practices were roughly three times
more likely to start antidepressants with people who
had memory problems compared with those who did
not. By way of contrast, the intervention locality was
much less likely to implement antidepressant therapy
with those with memory problems. Of people in the
control groupwithmemory problems, 34% (108/316)
were newly prescribed antidepressants compared with
9% (78/870) in the intervention practices (OR 0.19;
95% CI 0.13–0.27; P<0.001). Depression screening
tools were so infrequently used in both groups
(<0.1%) that these data could not be analysed.
There was a record of 16.1% (8658/53863) of the
control population and 16.7% (14856/88924) of the
intervention group having been referred to further
care at some time. However, many of these codes were
non-speciﬁc with less than 15% of the referrals speci-
fying psychiatric referral. The largest single group of
the speciﬁc relevant referral codes was referral to a
psychiatrist: 1.6% (1147/88 924) and 1.1% (591/53 863),
for intervention and control groups respectively, fell
into this category. The use of non-speciﬁc codes for
referral (‘Referral for further care’ was the most com-
mon)meant analysis below the level of referral was not
possible.
Overall 82% of people withmemory problems were
referred to secondary care. Of people in the inter-
vention group, 83.4% (n=739/886) were referred to
Table 1 Recording of memory problems by age band in intervention and control practices
Intervention locality Control locality
Age band Memory problem
n (%)
No memory
problem n (%)
Memory problem
n (%)
No memory
problem n (%)
<54 66 (0.1) 59 233 (99.9) 61 (0.1) 41 301 (99.9)
55–64 71 (0.6) 12 379 (99.4) 38 (0.6) 6247 (99.4)
65–74 111 (1.3) 8723 (98.7) 49 (1.4) 3527 (98.6)
75–84 –12 (5.2) 5716 (94.8) 98 (5.1) 1842 (94.9)
85 310 (13.4) 2003 (86.6) 70 (10.0) 630 (90.0)
All 870 (1.0) 88 054 (99.0) 316 (0.6) 53 547 (99.4)
Table 2 Numbers and proportion of people with and without memory problems who have
had four or more investigations post-intervention
Intervention locality Control locality
Age band Memory problem
n (%)
No memory
problem n (%)
Memory problem
n (%)
No memory
problem n (%)
<54 11 (16.7) 3310 (5.6) 8 (13.1) 2030 (4.9)
55–64 22 (31.0) 2925 (23.6) 15 (39.5) 1448 (23.2)
65–74 54 (48.6) 3197 (36.7) 23 (46.9) 1305 (37.0)
75–84 128 (41.0) 463 (43.1) 48 (49.0) 759 (41.2)
85 105 (33.9) 790 (39.4) 26 (37.1) 173 (27.5)
All 870 (100) 88 054 (100) 316 (100) 53 547 (100)
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secondary care compared with 78.4% (n=254/324) in
the control group (OR 1.29; 95% CI 0.99–1.93;
P=0.044). Referral was much more likely than inves-
tigation (40%) or antidepressant prescription (16%).
The rate of referral in the intervention locality was
static, changing from 313 referrals pre-intervention to
320 in the ten months after. The referral numbers in
the control group grew over the same period from 61
to 96 by approximately 150%. However, the inter-
vention practices referred a much higher proportion
of those with a new diagnosis of memory problems –
94% (497/529) for the intervention practices and 78%
(135/174) for the controls.
The intervention locality increased the number of
individuals prescribed cholinesterase inhibitors by
about one-third (100 to 137); in the control locality
prescribing more than doubled (16 to 42). Whilst the
absolute number of people prescribed cholinesterase
inhibitors was greater and increased more in the
intervention practices, the proportion of people with
memory problems prescribed was not signiﬁcantly
greater (OR 1.21; 95% CI 0.77–1.89; P=0.38). The
increase in the prescription of antidementia medi-
cation in the intervention practices appears to have
been due to patients who had ceased to comply
restarting medication.
Discussion
Principal ﬁnding
Routinely collected general practice computer data
demonstrates how the recording, investigation, referral
and treatment of patients with memory problems
changed during the leaﬂet campaign organised by
the Alzheimer’s Society.
The intervention locality had a higher baseline
recording ofmemory problems, referredmore of these
patients to secondary care and prescribed cholinester-
ase-inhibitors to more individual patients. However,
overall they investigated their patients no more than
the control locality and prescribed antidepressants to
people with memory problems less often.
Although the age–sex proﬁles of the intervention
and control locality were diﬀerent, theywere similar in
their recorded prevalence of memory problems, rate
of investigation, use of antidepressants, referral and
use of cholinesterase. What diﬀerences existed were
principally in the management of over-85-year-olds;
an age group highly pertinent to this study.
Implications for practice
A leaﬂet campaign may have a role in improving
quality in localities that are already achieving a good
standard of care. The intervention practices weremore
likely to record memory problems, refer and prescribe
antidementia medications. Currently the general prac-
tice ﬁnancially incentivised, quality-based contract has
possibly improved the standard of care, but itmay lack
incentives once practices have achieved their quality
points. This type of campaign may empower patients
to navigate their way more eﬀectively around the
National Health Service. However, other stimuli were
changing the control practices at a faster rate, although
they were starting from a lower base.
The leaﬂet campaign may have improved com-
pliance in people who had discontinued therapy. All
of the people who were additionally prescribed chol-
inesterase inhibitors were recorded as having been
Table 3 Numbers and proportion of people with and without memory problems who have
been newly prescribed antidepressant therapy
Intervention locality Control locality
Age band Memory problem
n (%)
No memory
problem
n (%)
Memory problem
n (%)
No memory
problem
n (%)
<54 7 (0.0) 3271 (5.5) 12 (19.7) 2947 (7.1)
55–64 9 (0.1) 1178 (9.5) 12 (31.6) 856 (13.7)
65–74 15 (0.4) 844 (9.7) 23 (46.9) 453 (12.8)
75–84 26 (1.3) 657 (11.5) 33 (33.7) 255 (13.8)
85 21 (3.0) 281 (14.0) 28 (40.0) 92 (14.6)
All 870 (100) 88 054 (100) 316 (100) 53 547 (100)
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prescribed thismedication prior to the ‘before’ period.
It is also of interest that, despite NICE guidance
regarding limiting their use,7 the number of prescrip-
tions for cholinesterase inhibitors is increasing.
Comparison with the literature
The Alzheimer’s Society has been active for many
years in raising the proﬁle of older people with
dementia and memory problems in older people.
These issues have been reﬂected in important recent
reports23–25 and in the controversy surrounding anti-
dementia drugs. It is feasible that the audit of routinely
collected datamight form an additional tool in raising
standards not incorporated within these reports.
There is some literature about the use of community
led leaﬂet campaigns as a quality improvement tool.
Previous campaigns, for example the ‘Defeat Depres-
sion’ campaign, have often concentrated on direct
communication with and education of GPs and other
primary care professionals, rather than focusing on
supplying patients with information backed up by
other information provision.26 Similar approaches
have been tried with asthma and have also shown
apparent success.27
Limitations of the study
The study demonstrates the strengths and weaknesses
of routinely collected data. Demographic details were
strong, with the exception of ethnicity recording. It is
hard to interpret apparent changes in prevalence; they
may represent a real increase in prevalence combined
with improvement in data quality.With computerised
laboratory links pathology data are largely complete,
though other investigations, such as brain scans, may
just be reported in hospital letters and not coded in the
general practice computer record.Computerised referral,
and more recent changes in the general practice
contract to encourage the use of screening question-
naires,may improve these data.Wedid not look at any
link between health economic status and prescrib-
ing.28
Call for further research
Comparing a single locality and its neighbour has
limitations. We were informed that contamination
was unlikely, as the two clinical communities had their
own meetings etc. However, it is likely that some
‘cross-border’ communication between community,
staﬀ and patients occurred. It would have been better
if the intervention could have been implemented at a
single practice level. This intervention might better be
tested using a cluster randomised design.
Conclusions
A community based campaign may have a role in
improving the quality of care; during this campaign
recording and management of memory problems
increased. Routinely collected data can be readily
collected from practices and processed to evaluate a
quality improvement initiative, though these data
have limitations. This study highlights the strengths
of routinely collected data in providing useful infor-
mation about people with memory problems and the
importance of including a comparator group in
studies.
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